key: cord-0804126-wr12k7bq authors: De-Leon, Hilla; Pederiva, Francesco title: Statistical mechanics study of the introduction of a vaccine against COVID-19 disease date: 2020-12-14 journal: Physical review. E DOI: 10.1103/physreve.104.014132 sha: 7472f74785b15aba3d3e9dc69ec0be9e84f0a0cc doc_id: 804126 cord_uid: wr12k7bq By the end of 2020, a year since the first cases of infection by the Covid-19 virus have been reported, there is a light at the end of the tunnel. Several pharmaceutical companies made significant progress in developing effective vaccines against the Covid-19 virus that has claimed the lives of more than a million people over the world. On the other hand, there is growing evidence of re-infection by the virus, which can cause further outbreaks. In this paper, we apply statistical physics tools to examine the vaccination rate required to control the pandemic for three different vaccine efficiency scenarios. Also, we study the effect of temporal restrictions/reliefs on the pandemic's outbreak, assuming that re-infection is possible. When examining the efficiency of the vaccination rate of the general population in preventing an additional outbreak of the disease, we find that a high vaccination rate (where at least 0.3% of the population is vaccinated daily, which is equivalent to ~ 1 million vaccine doses in the United States daily) is required to gain control over the spread of the virus without further restrictions. Due to feasible limitations on the vaccination rate, the vaccination process should be accompanied by the prevailing restrictions until most of the population is vaccinated. The COVID-19 disease has been spreading worldwide in the last year, whereby at the end of 2020, tens of millions have been infected from the virus and over a million people have died. Today, many companies and research institutes are in an advanced research stage to issue an efficient vaccine that will help to suppress the pandemic, eventually allowing for a faster return to the pre-corona life. As of this writing, at least two companies have reported proven efficacy of the vaccine 1,2 . As a result, in many countries worldwide, the question now arises about how the vaccine will affect the spread of the epidemic and what an effective rate of population vaccination will ensure control of the epidemic. Moreover, during the time that has passed since the first outbreaks of the epidemic, some evidence of re-infection with the virus has accumulated (see for example Refs. [3] [4] [5] [6] [7] [8] , and many more). The time extent of the coverage provided by a vaccine and the probability of re-infection after being subject to symptoms-free contagion or to the manifest disease have to be treated as separate issues from the medical perspective. However, it is clear that, whatever mechanism that changes a person's status from potentially covered from the disease to vulnerable, such time extent is a crucial parameter to establish whether an equilibrium condition with a controlled or zero level of infected people can be reached, avoiding another sequence of global outbreaks. Closely related to this mechanism, there are also two other parameters: the first is the actual effectiveness of the vaccine a) E-mail: hdeleon@ectstar.eu b) E-mail: francesco.pederiva@unitn.it (claimed at present to be of order 90%), and the second is the actual availability, which can be translated into the number of people who can be vaccinated in a given amount of time. In this paper, we address the study of the influence of such parameters on the evolution of the pandemics using basic principles of statistical mechanics similar to the method presented in Ref. 9 , where the population is modeled as a set of interacting classical particles. Each 'particle' can be in four states relative to the health status: susceptible of infection, infected, recovered/died (with 1% rate of death), and vaccinated. For the recovered people, we assume that re-infection can occur in periods ranging from 150 days from initial infection to one year later. Also, we assume that the vaccine efficiency varies from half a year (180 days) to two years, which is equivalent to infinity in the model's terms. All simulations were tested for different population densities, allowing us to apply the model to very different situations, ranging from a city suburb population to a single university classroom. The algorithm is based on standard Monte-Carlo (MC) procedures of sampling the transition among the following states, which are sampled from a statistical distribution, in the spirit of transport MC algorithms. Similarly to what reported in Ref. 9 , we are using a "oneway" Ising-model Monte-Carlo such that a healthy person (i) can become sick with a daily probability, P i = ∑ j P i j , where P i j is a function of the distance between each infected person ( j) in the area and the healthy person (i). Based on the epidemiology data, we assume that a sick person stops being sick (i.e., recovered or died) within an average time of ∼ 14 up to 40 days for the most severe cases, adding this time a finite probability of re-infection and a "vaccination" mechanism which switches a certain fraction of particles from the vulnerable stat to the immune state. In this approach, the parameter R t , the effective reproduc-tion rate of the virus, 10 is a direct outcome of the simulation and not pre-assumed. This is achieved by the relation between R t and the doubling time T d , which is a direct result of the infection probability chosen, which is, in turn, a function of observable epidemiological data and the average density on a given area. In this paper, we will present the results of several simulations meant to reproduce the spread of the Coronavirus in the presence of re-infection with and without an effective vaccine. Moreover, the model's high flexibility enables us to control the population density as a function of time and to simulate how temporary changes in R t affects the virus's spread. In Section II, we will describe some details of the model. Section III is devoted to the presentation and discussion of the results, and Sec. IV to the Conclusions. Given the scarce information available, we had to make some assumptions based on current data, which may be more stringent than it might be required by the real nature of the virus. In this work, similar to Ref. 9 , we based on Ref. 11 for the Coronavirus epidemiology data and on Refs. 12, 13 for the physical properties of the virus 14 All simulations are performed, assuming an initial surface area unit of 1 km 2 , wherein some simulations we increased/decreased the area as a function of time. The control over the surface area allows to change the simulation population density, which is equivalent to a temporary change of the parameter R t . The use of periodic boundary conditions reduces broad confinement effects (e.g., the lockdown of an entire province or city) and focuses at the local dynamics of the infections within that given area 15 Similar to Ref. 9 the population density is a function of the number of households in a certain area since it is crucial to distinguish between the infection among the family and non-household contacts 16 . This work has identified a list of parameters and corresponding values that describe the population and the infection's kinetics. 1. The number of effective households, denoted by N. 2. The fraction of "silent carriers," which have no symptoms (AKA asymptomatic) but can infect other people is denoted by a silent , and the probability of transmitting the infection has been set to 0.5. 3. Each sick person is considered contagious between the 3 rd and the 7 th day. 4. Simulations are started with a single infected person (the zero patient). Also, every day there is a chance of 20% that a healthy person (who is not recovered/vaccinated) becomes sick without interaction with a known sick person. Similar to Ref. 9 , our model is based on the principles of Brownian motion, such that for each day, the population position (R) and displacement (∆R) are given by: where ∆R = ∆x 2 + ∆y 2 is distributed normally: where ∆x (∆y) is displacement in the x-(y-) direction and σ 2 R , the variance, is a function of the diffusion constant, D: where t=1 day. For a Brownian motion the diffusion coefficient, D, would be related to the temperature, T , using the Einstein relation: where µ is defined as the mobility, k B is Boltzmann's constant and T is the absolute temperature. By fixing T = 1, the diffusion coefficient would be directly related to mobility. In our model, during all the time period, the population is allowed to move with σ R = 500 meter. We assume that this process can be described by a Gaussian function of the distance for each contact with another infected person, weighted with a factor that parametrizes the sick person's conditions and social interaction. 17 where: • r i (x i , y i ) is the location of the i th healthy person and r j (x j , y j ) is the location of the j th sick person, so |r i − r j | is the distance between them. • n sick is the total number of sick people in the area. • σ r is the standard deviation (here σ r = 2.4 meters) since recent studies show that even a slight breeze can drive droplets arising from a human cough over more than 6 meters 13 . • f (a silent , n out ) is a function that considers the social activity of the sick person and whether he has symptoms, which affects the spread of the virus outside the house. In our model, we estimate that infection by asymptomatic people is approximately 50% lower than patients with symptoms. • ξ is a number a random number uniformly distributed between 0 and 1, needed for converting to infection probability to a number between 0 and 1. • We are assuming that each sick person will infect some of his household members. Since the latest estimates are that household infections are ∼ 15% from the known cases (without lockdown, 18 ), we estimated that the number of household infections is are of uniformly distributed between 0 and 3. • During all the runs, we assume that people must wear face-masks so that the daily infection probability (for the non-household members, eq. 4), is reduced to [19] [20] [21] [22] [23] [24] int n sick • For all the simulations, people are forced to maintain a distance of 3 meters from each other (social distancing). With the continued spread of the COVID-19 virus worldwide, it appears that many countries are experiencing an increase in the rate of multiplication of patients per day at the time of outbreak stands at about doubling time, T d ≈ 10 days. This doubling time corresponds to R t ≈ 1.5, i.e., that each infection directly generates 1 − 2 more infections within countermeasures like social distancing and wearing masks. In our model, similar to Ref. 9 , both R t and T d are directly obtained from the simulation and not pre-assumed. We show in Fig. 1 the doubling time, T d for the first 14 days, as a function of the effective density, N, under the assumption of wearing masks and social distancing. We find that a value of T d ≈ 10 days, corresponding to R t = 1.5 25 , in the current model, would correspond to N = −.45 · 10 4 households per square kilometer, which is significantly lower than the density used in Ref. 9 and represents the social distance actions taken in many countries. Today, with various companies in the vaccine race, one of the questions arising these days is what vaccine rate will ensure maximum protection. In this work, we have examined different infection scenarios under the assumption of possible re-infection for a population density of households per squared kilometer, with and without an effective vaccine. When there is also a vaccine in the following scenario, we have considered the possibility that the vaccine's effectiveness is limited in time. Note that here we present the number of active cases as a function of time (how many people are sick at any given moment) since this is the measure of the health system's capacity threshold in different countries. As in our previous work, the different probability densities are calculated using standard techniques, in the spirit of a kinetic Monte-Carlo simulation, for predicting the number of active Coronavirus cases in a specific area. Each case has been run 100 times 26 In this subsection, we examine how the possibility of reinfection can affect the number of active cases as a function of time. Figure 2 shows our numerical results for the different simulations for the case of R t = 1.5 in the first 14 days, without any further restrictions nor reliefs, which can affect R t . In Fig. 2 , we show our calculations for different re-infection cases, ranging from 150 days from the time of initial infection to 300 days from the time of initial infection. From Fig. 2 , it is shown that even for low population density, re-infection can cause a second wave of infection, at an intensity that is not negligible compared to the first wave. As previously pointed out, the numerical results, presented in Fig. 2 , do not make any assumption on the doubling time, T d , but only on some observed features of the disease and the population density. Hence, we examined how a temporal change of the population density, which affects R t , the effective reproduction number of the virus, will be expressed in the number of cases under the assumption of re-infection. In our modal, the temporal reduction in population density is equivalent to the restrictions that are now contained worldwide due to the increase in the virus's morbidity, while a temporal increase in population density is equivalent to a release in the restrictions. Therefore, in Fig. 3 , we present how a temporal Figure 3 shows that a temporal change in less than 40% in the surface area, i.e., a change in effective population density, can cause a difference in order of magnitude in the number of infected. This result is consistent with the results from 9 , which examined the effect of mobility on the coefficient of infection. Also, it is seen that increasing the surface area (which is equivalent to reducing the population density or reducing the average number of contacts per person) by 40% can reduce the number of people infected as a function of time even without a vaccine. Hence, in Fig. 4 we show how a temporal increase of R t (Which in simulations is represented by temporary change in population density), can affect another outbreak of the virus for three different population densities, also for the case that further infection can occur only after a year. Figure. 4 shows how increasing R t after 200 days will affect the degree of infection for different population densities. It can be seen that for the case of a low initial R t (population density of 0.3 · 10 4 household per 1 sq km), increasing the population density by 1.4 times results in the second wave of infection, which is almost an order of magnitude higher than the first wave, even for a possible re-infection after a year. For a medium initial R t (population density of and 0.45 and 0.55 ·10 4 household per 1 sq km), there is a difference between a re-infection after 150 days and after one year. In the case of prolonged immunity from further infection, we find that even Fig. 2 and is omitted for improving the readability of the figure. in the first wave. For a short immunity case, an increase in population density will cause a second wave similar to the first one. Note that for all cases, a situation in which almost 10% of the population is ill at the same time is above the capacity threshold of the health system in most of the world, such that countries will take drastic actions to reduce the rate of infec-tion. In the next subsection, we test different vaccination situations for the case of re-infection. In this subsection, we test various simulations for the case of an effective vaccine. In this work, we examine how the efficiency of the vaccine can reduce the number of active cases for three different cases (for all case, we assumed the re-infection without vaccination could occur after 150 days); the first, when we assume that Fig. 2 and is omitted for improving the readability of the figure. the vaccine is valid only for half a year (180 days), i.e., after 180 days there is a chance that a person who has been vaccinated will become infected, the second, where the vaccine is efficient for a whole year and the third, where the vaccine is efficient for two years, i.e., infinity for our model. For all models, a certain percentage of the population is vaccinated starting from the 100 th day at daily rates ranging from 1% of the population to 0.1% percent each day (i.e., from the 100 th days, the vaccinated populations is protected from infection). Figure. 5 shows the number of active cases as a function of the efficacy of the vaccine and the vaccination rate (i.e., the percentage of people who can be vaccinated every day). Figure. 5 indicates that the impact of the vaccination rate on the daily number of patients is much higher than its efficiency. From Fig. 6 , we see that a vaccination rate of 0.1% of the population per day (which is equivalent to∼300,000 vaccine doses daily in the United States for at least a year) will not significantly reduce morbidity even for an infinite efficiency. Figure. 6 is an insert of Fig. 5 from the 200 th day, where dif-ferent percentages are marked for convenience. From Fig. 6 it easy to see that when a ∼ 1% of the population can be vaccinated daily, the effectiveness of the vaccine does not affect morbidity since the rate of immunization is higher than the rate of decline in immune protection even for the efficacy of only 180 days. On the other hand, when the rate of protection decreases faster than the rate of vaccination of the population, there is a difference between the efficiencies of 180 days and 720 days (i.e., infinity). For example, for a 720-day immunization efficacy, a vaccination rate of 0.2% of the population per day would result in similar immunization rates of 0.33% of the population per day, for a vaccination efficacy of only 180 days, where for both cases, the maximal percentage of infected people is ∼ 0.5%. Therefore, as long as the effectiveness of the vaccine is unknown and the entire population cannot be massively vaccinated, it will be necessary to maintain the social restrictions to prevent outbreaks of the pandemic (i.e., a vaccination rate of 0.14% means that about one million people in Europe will be vaccinated daily). Also, by comparing to Fig. 3 , we find that reducing the effective population density by 20% (which can be achieved by enforcing various social constraints) leads to a vaccine-like effect of a daily vaccination rate of 0.2% of the entire population. Hence, social distancing and wearing masks will have to be maintained even after vaccinating part of the population to reduce the R t as much as possible and to prevent another outbreak of the pandemic. Hence, it of interest to examine the effect of temporary changes in R t , in the case of an effective vaccine (720 days) with a vaccination rate of approximately 0.2% of the population each day. We assume that naturally, vaccination of the population will lead to a loosening of the strictness of the restrictions, which, as a result, will affect R t . Figure. 7 indicates that for a vaccination rate of 0.2 %, an uncontrolled release of the restrictions will lead to an increase in R t and, and as a result, to a further outbreak of the pandemic. For example, increasing the population density by about 20% will result in a maximum active percentage of patients of 2 % . On the other hand, vaccinating the population, which will be accompanied by restrictions that parallel the reduction of the population density by 20 %, will result in a maximum active percentage of patients of 0.2 %. Hence, during the immunization period, the public must observe the restrictions and wear masks, and that masks have to be worn until a significant percentage of the population was vaccinated. In this paper, we presented a kinetic Monte-Carlo algorithm for modeling different scenarios of spreading the COVID-19 under the assumption of possible re-infection and an efficient vaccine. The model's main advantage is its extreme flexibility, such that we can test many infection scenarios with a minimal computational cost. In this work, we studied how the possibility of re-infection affects the epidemic outbreak for different scenarios. Also, we examined how a temporary change in R t , the effective reproduction rate of the virus, has an influence on the reemergence of the pandemic when we assume the possibility of re-infection and infection from unknown sources, and how an effective vaccine would affect an infection recurrence in this situation. We found that even with a relatively low effective reproduction rate of the virus, i.e., R t ≈ 1.5, (which is a result of social distancing and local restrictions), a significant percentage of the population should be vaccinated to prevent the outbreak of a virus. Hence, in principle, our model might be used as a tool for decision-making concerning the rate of vaccination and for deciding which populations should be vaccinated first for a limited amount of vaccines, depending on the healthcare system capacity threshold in each country. Nevertheless, our results show that as long as a significant percentage of the population is not vaccinated, social distance regulations will have to be enforced, and people will continue to wear masks to reduce R t as much as possible to prevent an outbreak of the pandemic. Moderna's covid-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the phase 3 cove study Clinical recurrences of covid-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? A case report of possible novel coronavirus 2019 reinfection Risk of reactivation or reinfection of novel coronavirus (covid-19) Seasonal coronavirus protective immunity is short-lasting Predictive factors for a new positive nasopharyngeal swab among patients recovered from covid-19 More people are getting covid-19 twice, suggesting immunity wanes quickly in some Particle modeling of the spreading of coronavirus disease (covid-19) Note that the onset of the epidemic was characterized by the parameter R 0 , the basic reproducing number. Now, in many countries Sars-cov-2 (covid-19) by the numbers Likelihood of survival of coronavirus in a respiratory droplet deposited on a solid surface On coughing and airborne droplet transmission to humans We are aware that this model cannot take into account every single spreading event, but since such events affect the initial T d , (which is a function of the population density), and since the infection process is random, we expect that the existence of such events will be reflected in the numerical results. Also, in contrast to real-life, here, there is no time gap between the infection and being tested positive for Coronavirus. Therefore, an immediate decrease in the rate of infection resulting from lockdown is The application of periodic boundary conditions means that we have an infinite number of identical systems if a person leaves the simulation surface on one side, an equal person will enter the surface from the other side The characteristics of household transmission of COVID-19 Since the infection probability is a function of the absolute value of the distance between two people and the standard deviation, several distributions such as a Gaussian distribution and a Lorentzian distribution could serve for modeling the infection probability under the assumption that the simulation's dynamics dependents on σ r and not on the distribution's tail. The choice of Gaussian distribution was since this is the typical distribution for thermal systems approaches for equilibrium Household secondary attack rate of covid-19 and associated determinants Hku hamster research shows masks effective in preventing covid-19 transmission -fight covid Efficacy of face coverings in reducing transmission of covid-19: calculations based on models of droplet capture To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the covid-19 pandemic Host-to-host airborne transmission as a multiphase flow problem for science-based social distance guidelines Reducing transmission of sars-cov-2 The relation between T d and R t as shown in Fig. 1 means that attempting to describe a wide area's current situation by means of some average value of R t might be highly unappropriated Note that each run starts with the same initial condition, only one sick person. Since the Monte Carlo algorithm is based on random numbers, we expect that every run will yield slightly different results. Repeating the simulation for 100 separated runs evaluates the algorithm's robustness We thank R. Milo and his group at Weizmann Institute of Science for sharing their epidemiological data and for fruitful discussions. We thank G. Haimovich at Weizmann Institute of Science for fruitful discussions.The data that support the findings of this study are available from the corresponding author upon reasonable request.